Sensius
PrivateLast Round
Series A
Jun 11, 2025
Total Funding Raised
$27.39M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sensius is a medical technology company developing a precision thermotherapy platform designed to enhance standard cancer treatments such as radiotherapy and chemotherapy.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sensius Comparables
Compare Sensius with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pyrexar Medical | 89% | |
| ALBA Hyperthermia | 86% | |
| Andromedic Srl | 83% |
Sensius Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 11, 2025 | ||||
| Accelerator | Feb 15, 2023 | ||||
| Grant | Jun 20, 2022 | ||||
| Seed | Jul 11, 2017 |
Key People
Founding team and executive leadership
Sensius Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series A, Grant |
| UCEA Capital Partners | Series A |
| GrayBella Capital | Series A |
| InnovationQuarter | Seed |
| EIC Fund | Accelerator |
| Erasmus MC O&O Holding B.V. | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 4, 4x the trailing average.
- Dec 26, 2025
Grew 27% QoQ, from 11 to 14 employees.
Sensius Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sensius's valuation, stock price, and market status.
Is Sensius a public or private company?
Sensius is a private company.
What is the current stock price of Sensius?
Sensius is a private company with no public stock price. No recent secondary market data is available.
How much is Sensius worth (valuation)?
Valuation information for Sensius is not publicly available.
Can I buy Sensius stock?
Sensius shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sensius's last funding round?
Sensius's most recent funding round was Series A on June 11, 2025.
Who are the main investors in Sensius?
Key investors in Sensius include European Innovation Council, UCEA Capital Partners, GrayBella Capital, InnovationQuarter, EIC Fund.
Will Sensius IPO soon?
No public IPO plans have been announced for Sensius.
How can I track Sensius secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sensius's secondary market activity and sign up for updates.